COVID-19 Vaccine (inactivated, adjuvanted) Valneva is indicated for the prevention of COVID-19 in people aged between 18 and 50.

The vaccine causes the immune system to produce antibodies and blood cells against the virus, thus providing protection from COVID-19. None of the components of this vaccine can cause COVID-19.

The European Commission withdrew the marketing authorisation for Valneva in the European Union. The withdrawal was at the request of the marketing authorisation holder, Valneva Austria GmbH, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.